Literature DB >> 15745093

Effects of orthotopic liver transplantation on the corrected QT interval in patients with end-stage liver disease.

Elizabeth J Carey1, David D Douglas.   

Abstract

Autonomic dysfunction is a recognized complication of end-stage liver disease (ESLD) associated with a poor prognosis. The corrected QT interval (QTc) on electrocardiogram is a marker of autonomic function. A few small studies have suggested that QTc may normalize with the return of liver function after orthotopic liver transplantation. We sought to determine how transplantation affects the QTc in patients with ESLD. The QTc from the pretransplantation evaluation of 46 patients with ESLD was compared with the QTc at 4-month posttransplantation follow-up. Other factors that can influence autonomic function also were evaluated. Most patients with ESLD (54%) showed a prolonged QTc (> or = 440 msec) at the pretransplantation evaluation (451 +/- 45 msec) that improved to within the normal range at posttransplantation follow-up (418 +/- 18 msec; P < 0.001). There was no relationship between QTc prolongation and Child-Turcotte-Pugh score, Model for End-Stage Liver Disease score, diabetes mellitus, age, or etiology of liver disease. Most patients with ESLD and a prolonged QTc will have a significant improvement in QTc after transplantation; however, 6.5% of patients in our study had a worsening of QTc after transplantation.

Entities:  

Mesh:

Year:  2005        PMID: 15745093     DOI: 10.1007/s10620-005-1603-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  QT prolongation and Torsades de Pointes after administration of FK506.

Authors:  M C Johnson; S So; J W Marsh; A M Murphy
Journal:  Transplantation       Date:  1992-04       Impact factor: 4.939

2.  Autonomic dysfunction in patients with non-alcoholic chronic liver disease.

Authors:  M I Oliver; R Miralles; J Rubíes-Prat; X Navarro; J M Espadaler; R Solá; M Andreu
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

3.  Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis.

Authors:  L Puthumana; V Chaudhry; P J Thuluvath
Journal:  J Hepatol       Date:  2001-12       Impact factor: 25.083

4.  QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report.

Authors:  S P Hodak; J B Moubarak; I Rodriguez; M C Gelfand; M R Alijani; C M Tracy
Journal:  Transplantation       Date:  1998-08-27       Impact factor: 4.939

5.  Autonomic neuropathy and chronic liver disease.

Authors:  P J Thuluvath; D R Triger
Journal:  Q J Med       Date:  1989-08

6.  Q-T interval prolongation in liver cirrhosis. Reversibility after orthotopic liver transplantation.

Authors:  G Finucci; F Lunardi; D Sacerdoti; R Volpin; A Bortoluzzi; G Bombonato; P Angeli; A Gatta
Journal:  Jpn Heart J       Date:  1998-05

7.  Natural history of autonomic neuropathy in chronic liver disease.

Authors:  M T Hendrickse; P J Thuluvath; D R Triger
Journal:  Lancet       Date:  1992-06-13       Impact factor: 79.321

Review 8.  Probable case of torsades de pointes induced by fluconazole.

Authors:  Minou Khazan; A Scott Mathis
Journal:  Pharmacotherapy       Date:  2002-12       Impact factor: 4.705

9.  Impairment of autonomic reflexes in cirrhosis.

Authors:  A J MacGilchrist; J L Reid
Journal:  Am J Gastroenterol       Date:  1990-03       Impact factor: 10.864

10.  Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease.

Authors:  J F Fleckenstein; S m Frank; P J Thuluvath
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

View more
  10 in total

1.  QT interval prolongation in end-stage liver disease cannot be explained by nonhepatic factors.

Authors:  Divyang Patel; Prabhpreet Singh; William Katz; Christopher Hughes; Kapil Chopra; Jan Němec
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-04-24       Impact factor: 1.468

2.  Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation.

Authors:  Khemika Khemakanok; Anant Khositseth; Suporn Treepongkaruna; Sumate Teeraratkul; Wichai Pansrimangkorn; Surasak Leelaudomlipi; Uthen Bunmee; Suthus Sriphojanart
Journal:  Hepatol Int       Date:  2015-10-13       Impact factor: 6.047

3.  Alterations in corrected QT interval following liver transplant in patients with end-stage liver disease.

Authors:  Andrew O Zurick; Bret J Spier; Thomas C Teelin; Katelin R Lorenze; Cesar Alberte; Steven Zacks; Mary J Lindstrom; Patrick R Pfau; Kimberly Selzman
Journal:  Clin Cardiol       Date:  2010-11       Impact factor: 2.882

Review 4.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

5.  QT and outcomes in cirrhosis: A prolonged debate on causality in need of correction.

Authors:  Nikhilesh R Mazumder; Lisa B VanWagner
Journal:  Am J Transplant       Date:  2020-08-05       Impact factor: 9.369

6.  The Relationship between QT Interval Dispersion and End-Stage Liver Disease Score in the Patients Undergoing Orthotopic Liver Transplantation.

Authors:  Moghgan Zahmatkeshan; Ebrahim Fallahzadeh; Seyedeh Sadat Najib; Hamid Amoozgar; Seyed Ali Malekhosseini; Saman Nikeghbalian
Journal:  Int Cardiovasc Res J       Date:  2013-12-01

Review 7.  Molecular mechanisms underlying gallic acid effects against cardiovascular diseases: An update review.

Authors:  Ghaidafeh Akbari
Journal:  Avicenna J Phytomed       Date:  2020 Jan-Feb

8.  Propofol prevents further prolongation of QT interval during liver transplantation.

Authors:  Seung Hyun Kim; Jae Geun Lee; Hyang Mi Ju; SuYoun Choi; Hyukjin Yang; Bon-Nyeo Koo
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

9.  The Correlation between Echocardiographic Findings and QT Interval in Cirrhotic Patients.

Authors:  Alireza Moaref; Mahmood Zamirian; Maryam Yazdani; Oveis Salehi; Mehrab Sayadi; Kamran Aghasadeghi
Journal:  Int Cardiovasc Res J       Date:  2014-04-01

10.  QT prolongation is associated with increased mortality in end stage liver disease.

Authors:  Sun Moon Kim; Bennet George; Diego Alcivar-Franco; Charles L Campbell; Richard Charnigo; Brian Delisle; Jonathan Hundley; Yousef Darrat; Gustavo Morales; Samy-Claude Elayi; Alison L Bailey
Journal:  World J Cardiol       Date:  2017-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.